KR960006921A - 약학 조성물 - Google Patents

약학 조성물 Download PDF

Info

Publication number
KR960006921A
KR960006921A KR1019950027004A KR19950027004A KR960006921A KR 960006921 A KR960006921 A KR 960006921A KR 1019950027004 A KR1019950027004 A KR 1019950027004A KR 19950027004 A KR19950027004 A KR 19950027004A KR 960006921 A KR960006921 A KR 960006921A
Authority
KR
South Korea
Prior art keywords
nizatidine
methyl
methylthio
nitroethyleneamine
heated
Prior art date
Application number
KR1019950027004A
Other languages
English (en)
Inventor
케이 맥컬리 메리
필립 모더 케네쓰
린 스피크만 제프리
Original Assignee
피터 지. 스트링거
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 피터 지. 스트링거, 일라이 릴리 앤드 캄파니 filed Critical 피터 지. 스트링거
Publication of KR960006921A publication Critical patent/KR960006921A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명은 냄새 없는 니자티딘의 약학 조성물을 제공한다. 또한, 본 발명은 신규한 형태의 니자티딘 및 이의 제조 방법을 제공한다.

Description

약학 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (17)

  1. 물 존재하에서 가열하여 N-메틸-1-메틸티오-2-니트로에틸렌아민을 제거한 니자티딘의 약학 조성물.
  2. 제1항에 있어서, 수용액 또는 기포성 정제인 약학 조성물.
  3. N,N'-비스[2-[[[2-[2-(디메틸아미노)-메틸]-4-타이졸]메틸]-티오]에틸-2-니트로-1,1-에텐디아민 및 N,N'-디메틸-2-니트로-1,1-에텐디아민을 함유하나, N-메틸 -1-메틸티오-2-니트로에틸아민을 함유하지 않는 형태의 니자티딘의 약학 조성물.
  4. 제3항에 있어서, 수용액 도는 기포성 정제인 약학 조성물.
  5. 물 존재하에서 N-메틸-1-메틸티오-2-니트로에틸렌아민을 함유하는 니자티딘을 가열하여 상기 N-메틸-1-메틸티오-2-니트로에틸렌아민을 제거함을 포함하는 한 형태의 니자티딘의 제조방법.
  6. 제5항에 있어서, N-메틸-1-메틸티오-2-니트로에틸렌아민을 함유하는 니자티딘을 수중에서 가열하는 방법.
  7. 제6항에 있어서, N-메틸-1-메틸티오-2-니트로에틸렌아민을 함유하는 니자티딘을 니자티딘 kg당 물 0.3 내지 2.0 리터중에서 가열하는 방법.
  8. 제7항에 있어서, 니자티딘 kg당 물의 양이 0.45 내지 0.55 리터 범위내에 있는 방법.
  9. 제5항 내지 제8항중 어느 한 항에 있어서, 상기 니지티딘을 70 내지 110℃범위내의 온도에서 가열하는 방법.
  10. 제9항에 있어서, 상기 니자티딘을 90 내지 105℃범위내의 온도에서 가열하는 방법.
  11. 제10항에 있어서, 상기 니자티딘을 환류 가열하는 방법.
  12. 제5항 내지 제11항 중 어느 한 항에 있어서, 상기 니자티딘이 N-메틸-1-메틸티오-2-니트로에틸렌아민을 5,000ppm 이하의 양으로 함유하는 방법.
  13. 제12항에 있어서, 상기 니자티딘이 N-메틸-1-메틸티오-2-니트로에틸렌아민을 40 내지 1,500ppm 함유하는 방법.
  14. 제5항 내지 제13항 중 어느 한 항에 있어서, 상기 니자티딘 형태를 결정화시키는 단계를 또한 포함하는 방법.
  15. 제14항에 있어서, 상기 니자티딘 형태를 아세톤, 에탄올, 물 및 이들의 혼합물 중에서 선택한 용매를 사용하여 결정화시키는 방법.
  16. 제5항의 방법에 의해 제조된 형태의 니자티딘.
  17. N,N'-비스[2-[[[2-[2-(디메틸아미노)-메틸]-4-타이졸]메틸]-티오]에틸-2-니트로-1,1-에텐디아민 및 N,N'-디메틸-2-니트로-1,1-에텐디아민을 함유하나, N-메틸 -1-메틸티오-2-니트로에틸아민을 함유하지 않는 형태를 니자티딘.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950027004A 1994-08-30 1995-08-29 약학 조성물 KR960006921A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/298,486 US5470865A (en) 1994-08-30 1994-08-30 Pharmaceutical composition
US08/298,486 1994-08-30

Publications (1)

Publication Number Publication Date
KR960006921A true KR960006921A (ko) 1996-03-22

Family

ID=23150736

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950027004A KR960006921A (ko) 1994-08-30 1995-08-29 약학 조성물

Country Status (24)

Country Link
US (1) US5470865A (ko)
EP (1) EP0704214B1 (ko)
JP (1) JPH0892087A (ko)
KR (1) KR960006921A (ko)
CN (1) CN1127635A (ko)
AT (1) ATE192039T1 (ko)
AU (1) AU700488B2 (ko)
BR (1) BR9503832A (ko)
CA (1) CA2157240A1 (ko)
CO (1) CO4410183A1 (ko)
CZ (1) CZ189395A3 (ko)
DE (1) DE69516475T2 (ko)
ES (1) ES2145221T3 (ko)
FI (1) FI954050A (ko)
HU (1) HUT72672A (ko)
IL (1) IL115012A0 (ko)
NO (1) NO952825L (ko)
NZ (1) NZ272833A (ko)
PE (1) PE33696A1 (ko)
PH (1) PH31452A (ko)
PL (1) PL310207A1 (ko)
TR (1) TR199500885A2 (ko)
YU (1) YU57495A (ko)
ZA (1) ZA957281B (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010068707A (ko) * 2000-01-07 2001-07-23 최용준 시계줄
KR20200122007A (ko) * 2019-04-17 2020-10-27 황용석 순금 장식연결구 및 그 제조방법

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001240534A (ja) * 2000-02-29 2001-09-04 Bio Kagaku Kk 液状組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
DE3486032T2 (de) * 1983-02-07 1993-05-19 Lilly Co Eli Synthese von nizatidin.
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
IL80961A0 (en) * 1985-12-18 1987-03-31 Lilly Co Eli Synthesis of nizatidine
US4857344A (en) 1986-12-31 1989-08-15 Del Monte Corporation Method for treating pineapple to inhibit browning
DE3784698D1 (de) * 1987-04-06 1993-04-15 Heumann Pharma Gmbh & Co Verfahren zur herstellung von nitroethenderivaten.
DE68910308D1 (de) * 1989-05-10 1993-12-02 Council Scient Ind Res Verfahren zur Herstellung von 1-amino-substituierten 1-thio-substituierten 2-Nitro Alkenen.
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5334725A (en) * 1991-05-21 1994-08-02 Eli Lilly And Company 2-aminomethyl-4-exomethylenethiazoline epoxides
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010068707A (ko) * 2000-01-07 2001-07-23 최용준 시계줄
KR20200122007A (ko) * 2019-04-17 2020-10-27 황용석 순금 장식연결구 및 그 제조방법

Also Published As

Publication number Publication date
CO4410183A1 (es) 1997-01-09
CN1127635A (zh) 1996-07-31
FI954050A0 (fi) 1995-08-29
NO952825D0 (no) 1995-07-17
PE33696A1 (es) 1996-08-29
EP0704214A1 (en) 1996-04-03
AU700488B2 (en) 1999-01-07
DE69516475D1 (de) 2000-05-31
HUT72672A (en) 1996-05-28
YU57495A (sh) 1999-07-28
JPH0892087A (ja) 1996-04-09
CA2157240A1 (en) 1996-03-01
IL115012A0 (en) 1996-01-31
ES2145221T3 (es) 2000-07-01
AU3033495A (en) 1996-03-14
HU9502542D0 (en) 1995-10-30
FI954050A (fi) 1996-03-02
NO952825L (no) 1996-03-01
ATE192039T1 (de) 2000-05-15
DE69516475T2 (de) 2000-09-28
ZA957281B (en) 1997-02-28
US5470865A (en) 1995-11-28
CZ189395A3 (en) 1996-03-13
BR9503832A (pt) 1996-09-10
PH31452A (en) 1998-11-03
EP0704214B1 (en) 2000-04-26
TR199500885A2 (tr) 1996-06-21
PL310207A1 (en) 1996-03-04
NZ272833A (en) 1997-04-24

Similar Documents

Publication Publication Date Title
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
FI884626A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote
ATE69221T1 (de) Verfahren zur synthese von 3-thia-4chinolonderivaten und zwischenprodukte dafuer und ihre verwendung als arzneimittel.
NO850084L (no) N-(4-piperidinyl) bicyklisk kondenserte 2-imidazolaminderivater
ATE25974T1 (de) Acyl-substituierte derivate von 1,2,3,4tetrahydroisochinolin-3-carboxysaeuren, ihre salze, diese enthaltende arzneimittel und verfahren zu ihrer herstellung.
FR2430412B1 (fr) Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation
ES514267A0 (es) "un procedimiento para la preparacion de derivados de pirrolidina".
NO943895L (no) Galantaminderivater, en fremgangsmåte for fremstilling samt deres anvendelse som medikamenter
DK0629635T3 (da) Hidtil ukendte 19-nor-11beta-phenoxysulfonamid- eller 11beta-phenoxysulfonylureasteroider, fremgangsmåde og mellemprodukter til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
ES524680A0 (es) Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
BR9200171A (pt) Compostos e processos para a sua preparacao,composicao farmaceutica e usos dos ditos compostos
KR960006921A (ko) 약학 조성물
ATE19236T1 (de) (omega-(diaethylamino)-alkoxy)-alpha-(aethyl)benzhydrolderivate, ihre saeureadditionssalze und quaternaeren salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
KR910021394A (ko) 카르복실산 유도체
KR930012036A (ko) 골 흡수 억제용 약제학적 조성물
ATE62908T1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
IL64081A (en) N-alkoxycarbonyl-n'-substituted alkyl-n"-phenyl guanidines,process for their preparation and pharmaceutical compositions containing them
ATE11545T1 (de) Gesaettigte aminocyclitderivate, ihre herstellung und sie enthaltende arzneimittel.
KR860008168A (ko) 니트로푸란 유도체의 제조방법
US3322635A (en) Cosmetic composition exhibiting pantothenic acid activity
KR890009901A (ko) 3-히드록시-2-(4-메톡시페닐)-5-(2-메틸아미노에틸)-2,3-디히드로-5h-1,5- 벤조티아제핀-4-온 유도체, 그의 제조 및 치료에의 이용
KR940005600A (ko) 티오세미카바존 유도체
ATE1352T1 (de) Phenylalanyltryptophan-derivate, sie enthaltende arzneimittel, ihre herstellung und verwendung.
SE8405118L (sv) 4-kloro-furo-(3,4-c)-pyridin-derivat forfarande for framstellning derav och terapeutiska kompositioner innehallande dem

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid